Mechanisms underlying diabetes enhancement of endothelin-1-induced contraction in rabbit basilar artery

European Journal of Pharmacology

Volumn 486, Issue 3, 2004, Pages 289-296

  Alabadí, José A ^a   Miranda, Francisco J ^a   Lloréns, Silvia ^a   Centeno, José M ^a   Marrachelli, Vannina G ^a   Alborch, Enrique ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

(Rabbit); Basilar artery; Diabetes; Endothelin 1; Endothelium; NO (Nitric oxide)

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; INDOMETACIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; URIDINE TRIPHOSPHATE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 1242269738     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.01.005     Document Type: Article

References (33)

1. Alabadí J.A., Torregrosa G., Miranda F.J., Salom J.B., Centeno J.M., Alborch E. Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral vasospasm after subarachnoid hemorrhage? Neurosurgery. 41:1997;245-253.
2. Alabadí J.A., Miranda F.J., Lloréns S., Ruiz de Apodaca R.F., Centeno J.M., Alborch E. Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries. Eur. J. Pharmacol. 415:2001;225-232.
3. Barone F.C., White R.F., Elliott J.D., Feuerstein G.Z., Ohlstein E.H. The endothelin receptor antagonist SB217242 reduces cerebral focal ischemic brain injury. J. Cardiovasc. Pharmacol. 26(Suppl. 3):1995;S404-S407.
4. Cardillo C., Kilcoyne C.M., Waclawiw M., Cannon R.O. III, Panza J.A. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension. 33:1999;753-758.
5. Cardillo C., Campia U., Bryant M.B., Panza J.A. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 106:2002;1783-1787.
6. Chan N.N., Vallance P., Colhoun H.M. Nitric oxide and vascular responses in Type I diabetes. Diabetologia. 43:2000;137-147.
7. Chen S., Evans T., Mukherjee K., Karmazyn M., Chakrabarti S. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J. Mol. Cell. Cardiol. 32:2000;1621-1629.
8. Costa e Forti A., Fonteles M.C. Decreased endothelium dependent relaxation (nitric oxide) in diabetic kidneys. Horm. Metab. Res. 30:1998;55-57.
9. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130:2000;963-974.
10. Douglas S.A., James S., Hiley C.R. Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed. Br. J. Pharmacol. 103:1991;1441-1448.
11. Estrada V., Tellez M.J., Moya J., Fernández-Durango R., Egido J., Fernández-Cruz A.F. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am. J. Hypertens. 7:1994;1085-1089.
12. Hattori Y., Kawasaki H., Kanno M. Increased contractile responses to endothelin-1 and U46619 via a protein kinase C-mediated nifedipine-sensitive pathway in diabetic rat aorta. Res. Commun. Mol. Pathol. Pharmacol. 104:1999;73-80.
13. Hopfner R.L., Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia. 42:1999;1383-1394.
14. Hu J., Norman M., Wallensteen M., Gennser G. Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br. J. Obstet. Gynaecol. 105:1998;1279-1287.
15. Kakoki M., Hirata Y., Hayakawa H., Tojo A., Nagata D., Suzuki E., Kimura K., Goto A., Kikuchi K., Nagano T., Omata M. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B repector-mediated nitric oxide release from rat kidney. Circulation. 99:1999;1242-1248.
16. G-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 103:1991;1321-1326.
17. Lagaud G.J., Masih-Khan E., Kai S., Van Breemen C., Dube G.P. Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J. Vasc. Res. 38:2001;578-589.
18. Lukovits T.G., Mazzone T., Gorelick P.B. Diabetes mellitus and cerebrovascular disease. Neuroepidemiology. 18:1999;1-14.
19. Mankovsky B.N., Metzger B.E., Molitch M.E., Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J. Diabetes Its Complicat. 10:1996;228-242.
20. Mather K.J., Mirzamohammadi B., Lteif A., Steinberg H.O., Baron A.D. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes. 51:2002;3517-3523.
21. Mayhan W.G. Constrictor responses of the rat basilar artery during diabetes mellitus. Brain Res. 783:1998;326-331.
22. Mayhan W.G., Irvine S.D., Sharpe G.M. Constrictor responses of resistance arterioles during diabetes mellitus. Diabetes Res. Clin. Pract. 44:1999;147-156.
23. McIntyre C.A., Hadoke P.W.F., Williams B.C., Lindsay R.M., Elliot A.I., McKnight J.A. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with type I diabetes. Clin. Sci. 100:2001;311-318.
24. Miranda F.J., Alabadí J.A., Lloréns S., Ruiz de Apodaca R.F., Centeno J.M., Alborch E. Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine. Eur. J. Pharmacol. 401:2000;397-402.
25. Miranda F.J., Alabadí J.A., Llorens S., Ruiz de Apodaca R.F., Centeno J.M., Alborch E. Influence of experimental diabetes on regulatory mechanisms of vascular response of rabbit carotid artery to acetylcholine. Life Sci. 66:2000;2071-2080.
26. Miranda F.J., Alabadí J.A., Lloréns S., Ruiz de Apodaca R.F., Centeno J.M., Alborch E. Experimental diabetes induces hyperreactivity of rabbit renal artery to 5-hydroxytryptamine. Eur. J. Pharmacol. 439:2002;121-127.
27. Pagano P.J., Griswold M.C., Ravel D., Cohen R.A. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits. Diabetologia. 41:1998;9-15.
28. Petersson J., Andersson K.E., Brandt L., Hogestatt E.D. Modulation by the endothelium of the inhibitory effects of pinacidil and nimodipine on endothelin-induced contraction in cerebral arteries. Pharmacol. Toxicol. 80:1997;30-37.
29. Salom J.B., Torregrosa G., Miranda F.J., Alabadí J.A., Álvarez C., Alborch E. Effects of endothelin-1 on the cerebrovascular bed of the goat. Eur. J. Pharmacol. 192:1991;39-45.
30. Salom J.B., Centeno J.M., Torregrosa G., Ortí M., Barberá M.D., Alborch E. Vasoconstriction to endothelin-1 in the goat middle cerebral artery after transient global cerebral ischemia. J. Stroke Cerebrovasc. Dis. 9:2000;16-21.
31. Schneider J.G., Tilly N., Hierl T., Sommer U., Hamann A., Dugi K., Leidig-Bruckner G., Kasperk C. Elevated plasma endothelin-1 levels in diabetes mellitus. Am. J. Hypertens. 15:2002;967-972.
32. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido I., Kawamura T., Nyengaard J.R., Van den Enden M., Kilo C., Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813.
33. Zuccarello M., Boccaletti R., Rapoport R.M. Endothelin ET(B1) receptor-mediated relaxation of rabbit basilar artery. Eur. J. Pharmacol. 357:1998;67-71.